skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
NONE
Issue Dt:
Application #:
12626534
Filing Dt:
11/25/2009
Publication #:
20100183620
Pub Dt:
07/22/2010
Inventors:
KAUMUDI BHAWE, Elizabeth Bosch, Kathleen Boyle, Arthur Brace, Jeffrey Finer et al
Title:
COMPOSITIONS AND METHODS FOR REGULATING COLLAGEN AND SMOOTH MUSCLE ACTIN EXPRESSION BY SERPINE2
Assignment: 1
Reel/Frame:
024143/0561Recorded: 03/26/2010Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
BHAWE, KAUMUDI
Exec Dt:
03/12/2010
BOSCH, ELIZABETH
Exec Dt:
03/15/2010
BOYLE, KATHLEEN
Exec Dt:
03/12/2010
BRACE, ARTHUR D.
Exec Dt:
03/12/2010
FINER, JEFFREY T.
Exec Dt:
03/12/2010
PIERCE, KRISTEN
Exec Dt:
03/12/2010
SULLIVAN, KATHLEEN M.
Exec Dt:
03/12/2010
WONG, BRIAN
Exec Dt:
03/12/2010
Assignee:
FIVE PRIME THERAPEUTICS, INC.
1650 OWENS STREET
SUITE 200
SAN FRANCISCO, CALIFORNIA 94158
Correspondent:
SALVATORE J ARRIGO
1050 CONNECTICUT AVE. NW
10TH FLOOR
WASHINGTON, DC 20036
Assignment: 2
Reel/Frame:
026717/0156Recorded: 08/08/2011Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
DAS, ANUK
Exec Dt:
08/04/2011
FARRELL, FRANCIS
Exec Dt:
07/18/2011
SIVAKUMAR, PITCHUMANI
Exec Dt:
08/03/2011
Assignee:
JANSSEN BIOTECH, INC.
145 KING OF PRUSSIA ROAD
RADNOR, PENNSYLVANIA 19087
Correspondent:
DEB MOJARRO C/O FIVE PRIME THERAPEUTICS
2 CORPORATE DRIVE
SOUTH SAN FRANCISCO, CA 94080

Search Results as of: 05/21/2024 03:21 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT